You are here
Future Health - Ireland
AboutParent bank: Future Health Technologies
Future Health Biobank owns and operates two state-of-the-art laboratories: one in the UK and one in Switzerland. Future Health is licensed to transport biological samples around the world and to store cells and tissues for use by either the donor, the donor's family, or an unrelated person. In 2016 they launched a new diagnostics division to the company which offers a range of screening tests.
Future Health Technologies was founded in 2002 following 3 years of extensive research and was the first stem cell bank to receive a Human Tissue Authority (HTA) license in 2005. Today, Future Health has stored more samples than all other UK banks combined and as of June 2016 had in excess of 125,000 samples in storage.
- The UK’s largest stem cell bank having processed and stored more umbilical cord stem cell samples than all the other UK banks combined
- 125,000 stem cell samples are stored from over 75,000 families in 75 countries, with offices in over 38 countries worldwide
- The only cord blood bank in the world to own laboratories in both the UK and Switzerland
- The most highly accredited cord blood bank in the UK
- Released 25 samples for transplant/therapies to Europe, the Middle East and the US
- Expertise in processing and storing stem cells from dental pulp and adipose tissue
Future Health provides its clients with a purpose built collection kit containing all of the necessary components required to collect the samples. Included within the kit is a specially designed cord blood collection bag packed in individual aluminium sterile packaging.
Also provided, is a bespoke cord tissue collection kit, containing an antimicrobial tablet and a new and improved transportation preservation solution, to ensure the sample returns to the laboratory in the optimum state.
The cord blood and the cord tissue are transported in a thermally insulated shipping box designed by Future Health. It is fully accredited by the International Air Transport Association (IATA) for protection against adverse temperature and shipping conditions. The container includes a gel cool pack and a temperature data logger to monitor shipping conditions.
For cord blood, clients are offered the opportunity to opt for either Future Health’s Premium (volume reduced processing) method or its Standard (whole blood processing) method.
Future Health is the only bank in the UK to have its own in-house serology and PCR laboratories which perform tests for infectious diseases on the cord blood and maternal blood. In addition to this, Future Health also uses flow cytometry to confirm the number of stem cells successfully stored within the sample.
Future Health is also the only bank in the UK to perform viability testing on all cord tissue samples to ensure the cells are healthy and viable.
Parents are provided with a certificate of storage detailing their unique identity code, the volume of blood stored, stem cell counts, and confirmation of the cord tissue viability. All clients are also provided with the maternal blood test results and the outcome of the micro-contamination testing.
The samples are stored in multiple portions over separate storage locations which are all fully owned and maintained by Future Health. A member of the laboratory team is on call 24 hours per day to respond should there be any issues with the storage facility and there is also a security presence 24 hours per day.
The company maintains an insurance backed disaster recovery programme, which allows the transference of the samples to a suitably HTA licensed cryogenic storage facility in the highly unlikely event of a disaster at one of the company’s storage sites.
Licensing & Accreditation
Future Health Technologies is the most accredited stem cell bank in the UK. At present Future Health Technologies maintains the following licenses and accreditations:
- Human Tissue Authority (HTA) License (no. 22503)
- Medicines and Healthcare products Regulatory Agency (MHRA) Blood Establishment Authorisation
- GMP compliant laboratories
- ISO:9001 Quality Management Accreditation
- Prestigious Queen’s Award for Enterprise and International Trade
- AABB accreditation
Future Health has released 25 samples successfully for transplantations/therapies since 2012 to Europe, the Middle East and the US. These samples have been used to treat conditions such as Cerebral Palsy, Fanconi’s Anaemia, Severe Combined Immunodeficiency (SCID) and Beta Thalassemia.
Future Health believes that every family should have peace of mind when storing such a precious sample. That’s why Future Health offers every client private sample protection ensuring that in the unlikely event Future Health Technologies was to become insolvent, the sample would continue to be stored by an alternative HTA licensed storage facility.
Future Health Technologies is proud to offer a range of discounts designed to make stem cell banking accessible for everybody. These include:
- Price Beat Guarantee
- Repeat customer discount
- Twin/Triplet discounts
- Refer a friend scheme
- Special discount for immediate use cases
Future HealthTechnologies offers the following cord blood and cord tissue package prices:
Premium Service +Cord Service - £2250.00
Volume reduction cord blood + cord tissue with 25 years storage
Premium Service - £1755.00
Volume reduction cord blood with 25 years storage
Standard Service +Cord Service - £1995.00
Whole cord blood + cord tissue with 25 years storage
Standard Service - £1575.00
Whole cord blood with 25 years storage
Vision NIPT Test
Vision is non-invasive prenatal test which can be performed as early as 10 weeks into pregnancy. It is a safe, accurate and reliable prenatal test screening for life-altering conditions, including Down’s syndrome.
Outlook New Born Screening
Outlook is a simple, saliva based screening test for five conditions including lactose intolerance and coeliac disease.
Visit our website for the most up to date services and prices for each country.